R&D Focus Area

Biomedical Sciences and Health

Solving global health problems through drug discovery and development, clinical medicine, bioinformatics, genetics, neuroscience, health sciences, and medical device research and development

SRI researcher in a lab smiles at camera
artist's rendering of a human head with brainwaves going across it
Two SRI scientists working in a lab
twin brothers

SRI tackles the most challenging health problems, such as cancer, infectious diseases, and neurodegenerative disorders. We work in partnership with clients in academia, biotechnology and pharmaceutical companies, and foundations.

SRI is also a leading drug discovery contractor and preclinical development contractor for several government agencies, including the National Institutes of Health and the National Science Foundation. To improve and save lives, SRI researchers investigate disease mechanisms and develop new treatments.

Drug Discovery and Development

SRI Biosciences provides drug discovery and development capabilities to take drugs from ideas to the Investigational New Drug status (Idea to IND®). SRI's pipeline has produced several marketed drugs and advanced well over 100 drugs to clinical trials.

Learn more: Drug Discovery Services »
Learn more: Drug Development Services »
Learn more: Custom Assay Services »

Health Sciences

SRI's Health Sciences Section, part of SRI Biosciences, conducts basic research and contract R&D to advance programs in sleep, cognition, pain, addictionaging, obesity, and neurodegenerative diseases such as Alzheimer's and Parkinson's. We also strive to determine the environmental, behavioral, and biological contributors to human health and illness.

Learn more »

Medical Device Development

SRI’s multidisciplinary engineering has led to advanced medical and surgical devices such as novel diagnostic and drug delivery tools and devices sized for pediatric use.

Learn more »


SRI researchers develop computational approaches to address challenges in systems biology, such as elucidating metabolic pathways in bacteria and humans. Findings are shared with the global research community.

Learn more »